Update on Muscular Dystrophies with Focus on Novel Treatments and Biomarkers

This article reviews recent advances in the development of novel treatments and biomarkers in the realm of muscular dystrophies commonly encountered in pediatric population.Recent FindingsThe therapeutic landscape of muscular dystrophies has changed with the development of new approved treatments for Duchenne muscular dystrophy (DMD), the most common and severe muscular dystrophy. This has paved the way for the development of novel therapeutic strategies for not only DMD but also other muscular dystrophies.SummaryThis article reviews recent advances in the development of novel treatments and biomarkers in the realm of muscular dystrophies commonly encountered in pediatric population.
Source: Current Neurology and Neuroscience Reports - Category: Neuroscience Source Type: research